2D systems offering low radiation dosage to gain traction with the phasing out of traditional systems, finds Frost & Sullivan
SANTA CLARA, Calif., Oct. 1, 2018 /PRNewswire/ -- Highly populated countries have traditionally been slow adopters of non-conventional business models, but government initiatives to promote early tumor detection are expected to
For further information on this analysis, please visit: http://frost.ly/2r2
"Although analog and computed radiography (CR) mammography will continue to generate revenues from developing economies over the next three to five years, their increasing obsolescence will present considerable opportunities for 2D digital radiography (DR) systems," said Poornima Srinivasan, Industry Analyst, Transformational Health. "Studies show that digital breast tomosynthesis (DBT) is a game-changing technology for screening programs due to its ability to detect tumors in women with dense breast tissue. Similarly, 2D DR mammography with 3D DBT enhancement and synthesized 2D imaging also offer high price-performance value."
Frost & Sullivan's recent analysis, Global X-ray Mammography Imaging Systems Market, Forecast to 2022, analyzes various market trends such as the utilization of mammography systems, breast care statistics, mammography procedure volume analysis, and clinical layout of breast care. It covers growth indicators, growth strategies, competitive structure, and market share and revenues forecasts for North America, Europe, and Asia-Pacific. The product segments covered include analog, computed, 2D digital, 2D digital to DBT upgrade, and digital breast tomosynthesis.
"To further improve product uptake, vendors are positioning 3D with multi-modality views, setting up workstations with 2D and 3D comparisons, and creating advanced detectors and algorithms to detect cancer at an early stage," noted Srinivasan. "Significantly, they are also launching technologies such as contrast-enhanced spectral mammography, which provides low-energy 2D mammographic imaging on par with magnetic resonance imaging (MRI)."
Overall, vendors that are looking to expand their footprint in this market and monetize growth opportunities need to:
With technology developments in dose reduction, optimization, specificity, and sensitivity for early tumor detection, mammography will continue to be the preferred imaging tool for breast cancer detection.
Global X-ray Mammography Imaging Systems Market, Forecast to 2022 is part of Frost & Sullivan's global Advanced Medical Technologies Growth Partnership Service program.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Global X-ray Mammography Imaging Systems Market, Forecast to 2022MDD4-54
Contact:Mariana FernandezT: +1 210 348 10 12T: +54 11 4778 3540E: Mariana.Fernandez@frost.com
View original content:http://www.prnewswire.com/news-releases/x-ray-mammography-adoption-to-skyrocket-as-preferred-imaging-tool-for-breast-cancer-detection-300721804.html
SOURCE Frost & Sullivan
Subscribe to our Free Newsletters!